相似文献
1
A Practical Approach to Managing Hypoactive Sexual Desire Disorder in Women with Diabetes.
Diabetes Ther. 2017 Oct;8(5):991-998. doi: 10.1007/s13300-017-0313-0. Epub 2017 Sep 16.
2
Ignorance Is Not Bliss: If We Don't Understand Hypoactive Sexual Desire Disorder, How Can Flibanserin Treat It? Commentary.
J Sex Med. 2018 Mar;15(3):273-283. doi: 10.1016/j.jsxm.2018.01.001. Epub 2018 Feb 1.
3
Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
Expert Opin Pharmacother. 2015;16(16):2523-9. doi: 10.1517/14656566.2015.1090426. Epub 2015 Sep 22.
4
Pharmacotherapy of Hypoactive Sexual Desire Disorder in Premenopausal Women.
Ann Pharmacother. 2025 Feb;59(2):148-161. doi: 10.1177/10600280241253273. Epub 2024 May 20.
5
Evaluation and Management of Hypoactive Sexual Desire Disorder.
Sex Med. 2018 Jun;6(2):59-74. doi: 10.1016/j.esxm.2018.01.004. Epub 2018 Mar 6.
6
Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
J Sex Med. 2017 Jun;14(6):834-842. doi: 10.1016/j.jsxm.2017.03.258.
7
Hypoactive Sexual Desire Disorder: A Review of Epidemiology, Biopsychology, Diagnosis, and Treatment.
Sex Med Rev. 2016 Apr;4(2):103-120. doi: 10.1016/j.sxmr.2015.11.009. Epub 2016 Feb 6.
8
New developments in the treatment of hypoactive sexual desire disorder - a focus on Flibanserin.
Int J Womens Health. 2017 Apr 10;9:171-178. doi: 10.2147/IJWH.S125356. eCollection 2017.
9
Flibanserin: A controversial drug for female hypoactive sexual desire disorder.
Ind Psychiatry J. 2018 Jan-Jun;27(1):154-157. doi: 10.4103/ipj.ipj_20_16.
10
Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
J Womens Health (Larchmt). 2019 Jun;28(6):769-777. doi: 10.1089/jwh.2018.7516. Epub 2019 Feb 1.
引用本文的文献
1
Addressing Sexual Dysfunction in Women With Type 1 Diabetes.
Clin Diabetes. 2025 Jan 10;43(3):420-428. doi: 10.2337/cd24-0090. eCollection 2025 Summer.
2
[Sex and gender-specific aspects in prediabetes and diabetes mellitus-clinical recommendations (Update 2023)].
Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):275-285. doi: 10.1007/s00508-023-02185-5. Epub 2023 Apr 20.
3
Exploring Sexual Life Experiences and Perceptions of Women with Diabetes: A Qualitative Study.
Int J Community Based Nurs Midwifery. 2022 Jul;10(3):223-233. doi: 10.30476/IJCBNM.2021.91530.1793.
4
Prevalence of sexual dysfunction and related factors among diabetes mellitus patients in Southwest Ethiopia.
BMC Endocr Disord. 2019 Dec 18;19(1):141. doi: 10.1186/s12902-019-0473-1.
5
[Sex and gender-specific aspects in prediabetes and diabetes mellitus-clinical recommendations (Update 2019)].
Wien Klin Wochenschr. 2019 May;131(Suppl 1):221-228. doi: 10.1007/s00508-018-1421-1.
本文引用的文献
1
Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review.
Mayo Clin Proc. 2017 Jan;92(1):114-128. doi: 10.1016/j.mayocp.2016.09.018. Epub 2016 Dec 1.
2
Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
JAMA Intern Med. 2016 Apr;176(4):453-62. doi: 10.1001/jamainternmed.2015.8565.
3
Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab. 2014 Oct;99(10):3489-510. doi: 10.1210/jc.2014-2260.
4
Managing female sexual dysfunction.
Fertil Steril. 2013 Oct;100(4):905-15. doi: 10.1016/j.fertnstert.2013.08.026.
5
Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
J Sex Med. 2013 Jul;10(7):1807-15. doi: 10.1111/jsm.12189. Epub 2013 May 14.
6
Hypoactive sexual desire disorder in women: treatment options beyond testosterone and approaches to communicating with patients on sexual health.
Pharmacotherapy. 2013 Apr;33(4):411-21. doi: 10.1002/phar.1209.
7
Testosterone supplementation for hypoactive sexual desire disorder in women.
Pharmacotherapy. 2012 Jan;32(1):38-53. doi: 10.1002/PHAR.1004.
8
Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
J Sex Med. 2011 Nov;8(11):3160-72. doi: 10.1111/j.1743-6109.2011.02458.x. Epub 2011 Sep 20.
9
The pathophysiology of hypoactive sexual desire disorder in women.
Int J Gynaecol Obstet. 2010 Jul;110(1):7-11. doi: 10.1016/j.ijgo.2010.02.014.
10
A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women.
BJU Int. 2010 Sep;106(6):832-9. doi: 10.1111/j.1464-410X.2010.09208.x. Epub 2010 Feb 11.
Zotero 插件